Prosecution Insights
Last updated: August 16, 2026
Application No. 18/693,120

Composition

Final Rejection §102§103§112
Filed
Mar 18, 2024
Priority
Oct 21, 2021 — GB 2115101.4 +1 more
Examiner
MRUK, BRIAN P
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Givaudan S.A.
OA Round
2 (Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
982 granted / 1323 resolved
+9.2% vs TC avg
Strong +28% interview lift
Without
With
+27.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 2m
Avg Prosecution
50 currently pending
Career history
1366
Total Applications
across all art units

Statute-Specific Performance

§101
2.7%
-37.3% vs TC avg
§103
32.7%
-7.3% vs TC avg
§102
27.1%
-12.9% vs TC avg
§112
20.5%
-19.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1323 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION This Office action is in response to Applicant’s amendment filed June 3, 2026. Applicant has amended claims 1, 10, 15 and 26. Claim 16 has been cancelled. New claims 28 and 29 have been added. Currently, claims 1-13, 15 and 17-29 remain pending in the application. The text of those sections of Title 35 U.S. Code not included in this action can be found in the prior Office action, Paper No. 20260206. The rejection of claim 10 under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, is withdrawn in view of applicant’s amendments and remarks. The rejection of claims 15 and 26 under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, for containing the limitation “wherein the chitosan has a molecular weight” is maintained for the reasons of record. The rejection of claims 1-13 and 15-27 under 35 U.S.C. 102((a)(1)) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Berthier et al, WO 2020/127743, is withdrawn in view of applicant’s amendments and remarks. NEW GROUNDS OF REJECTION Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 12 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 12 recites the limitation "comprising at least one polysaccharide" in lines 6-7. There is insufficient antecedent basis for this limitation in the claim. Specifically, newly amended claim 1 requires the polysaccharide to be bacterial derived cellulose, diutan gum, and combinations thereof. Appropriate correction and/or clarification is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-13, 17-25 and 27-29 are rejected under 35 U.S.C. 102((a)(1)) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Caggioni et al, US 2012/0208737. Caggioni et al, US 2012/0208737, discloses a liquid detergent composition comprising an external structuring system comprising a bacterial cellulose network (see abstract). It is further taught by Caggioni et al that the composition contains 0.005-1% by weight of an external structuring system comprising a bacterial cellulose network, 30-75% by weight of water, 0.01-70% by weight of a surfactant system (see paragraph 6), that the bacterial cellulose network is produced via fermentation of a bacteria of the genus Acetobacter and includes microfibrillated cellulose and reticulated bacterial cellulose (see paragraph 23), that the composition further contains diutan gum and guar gum (see paragraph 41), that suitable surfactants include ethoxylated alcohols (see paragraphs 70-92), that the composition contains 0.001-10% by weight of perfume microcapsules (see paragraphs 115-119), 0.01-1.5% by weight of magnesium ions (see paragraphs 126-127), and adjunct ingredients for washing fabrics, such as perfumes (see paragraphs 140-145), wherein the composition is made by mixing the components (see paragraphs 146-168), per the requirements of the instant invention. Specifically, note Examples 1-10. Therefore, instant claims 1-13, 17-25 and 27-29 are anticipated by Caggioni et al, US 2012/0208737. In the alternative that the above disclosure is insufficient to anticipate the above listed claims, it would have nonetheless been obvious to the skilled artisan to produce the claimed composition, as the reference teaches each of the claimed ingredients within the claimed proportions for the same utility. Response to Arguments Applicant's arguments filed June 3, 2026 have been fully considered but they are not persuasive. The examiner notes that applicant’s remarks state that the amendments to claims 15 and 26 overcome the 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, rejections. However, the examiner respectfully disagrees. Specifically, the rejection of claims 15 and 26 under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, for containing the limitation “wherein the chitosan has a molecular weight” is maintained for the reasons of record. The examiner maintains that this limitation renders the claim vague and indefinite, since it is unclear if the molecular weight refers to the weight average molecular weight or the number average molecular weight of the chitosan component. Appropriate correction and/or clarification is required. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Boutique et al, EP 2,408,892, discloses structured fluid detergent compositions containing bacterial cellulose. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRIAN P MRUK whose telephone number is (571)272-1321. The examiner can normally be reached on 7:00am-5:30pm Monday-Thursday. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew, can be reached on 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRIAN P MRUK/ Primary Examiner, Art Unit 1761 Brian P Mruk July 29, 2026
Read full office action

Prosecution Timeline

Mar 18, 2024
Application Filed
Feb 10, 2026
Non-Final Rejection mailed — §102, §103, §112
Jun 03, 2026
Response Filed
Jul 31, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12703827
Composition with Mixed C8-C18 Alcohols and Surfactants Thereof
3y 8m to grant Granted Aug 11, 2026
Patent 12692460
A UNIT DOSE TABLET COMPOSITION
2y 8m to grant Granted Jul 28, 2026
Patent 12680057
FABRIC CARE COMPOSITION
2y 5m to grant Granted Jul 14, 2026
Patent 12673793
METHOD AND SYSTEM FOR MANUFACTURING A SHEET OF LAUNDRY DETERGENT
3y 3m to grant Granted Jul 07, 2026
Patent 12674118
STABLE ANHYDROUS DISH SOAP AND METHOD OF MAKING SAME
3y 0m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
99%
With Interview (+27.8%)
2y 2m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1323 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month